Johnson & Johnson’s robotic surgery and medical device division, Ethicon, is dropping $3.4 billion in cash to pick up Auris Health, a developer of robotic diagnostics and surgical devices initially focused on detecting and treating lung cancer. The healthcare giant said an additional $2.35 billion in payouts may be possible if Auris hits certain milestones. […]
View More J&J spends $3.4 billion in cash for Auris Health’s lung cancer diagnostics and surgical robotsKnowledge is POWER